Patent · US Active

Glypican 3 antibodies and conjugates thereof

US11819553B2 · kind B2 · utility

0Cited by
2References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 15, 2019
Grant dateNov 21, 2023
Priority date—
Expiry dateMar 26, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides murine, chimeric, and humanized antibodies that specifically bind to GPC3 and conjugates thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.